FDA Accelerated Approval Boosts Hope for Fatal Diseases
Despite criticism stemming from contentious biomarkers and failed confirmatory trials, the FDA’s accelerated approval pathway continues to drive therapeutic innovation for some of the world’s most complex and pressing medical…
Biopharma Tackles Deadly Brain Cancer After Years of Setbacks
Technological breakthroughs and deeper insights into glioblastoma are revitalizing efforts to tackle this aggressive brain tumor. Companies like Merck, Kazia Therapeutics, CorriXR Therapeutics, and others are leading the charge, raising…
GE HealthCare Showcases AI-Driven Innovations and Precision Care Solutions at RSNA 2024
At the 2024 Annual Meeting of the Radiological Society of North America (RSNA), held December 1-4 in Chicago, GE HealthCare (Nasdaq: GEHC) is presenting over 40 groundbreaking innovations. These include…
Laser Photonics Launches R&D Initiative to Drive Innovation
Laser Photonics Corporation a global leader in the development of industrial laser systems for material processing applications, has announced the launch of a new research and development (R&D) initiative aimed…
Devonian Reports 2024 Annual Financial Results
Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a clinical-stage botanical pharmaceutical company specializing in the development of unique botanical pharmaceutical and cosmeceutical products, has announced its financial…
Generic Injectables Market Report 2024-2030: Patent Expirations and New Opportunities
The global Generic Injectables market, valued at $95.2 billion in 2023, is on a strong growth trajectory and is projected to reach $206.8 billion by 2030, growing at a CAGR…
Bayer Expands Global Incubator Network with Co.Lab Berlin, Welcomes MyoPax as First Resident
Bayer has inaugurated Bayer Co.Lab Berlin, a state-of-the-art life science incubator located at the company’s Pharmaceuticals Division Global Headquarters Campus. Positioned near leading research and clinical institutions in Berlin, the…
UCB Advances New Launches and Divests Mature Product Business in China
UCB, a global biopharmaceutical leader, has announced the successful completion of its sale, divestment, and licensing agreement for its mature neurology and allergy portfolio in China. The transaction, valued at…
EU Approves BeiGene’s TEVIMBRA for Advanced Esophageal and Gastric Cancer Treatment
BeiGene has announced that the European Commission has approved TEVIMBRA® (tislelizumab) in combination with chemotherapy as a first-line treatment for two aggressive cancer types: esophageal squamous cell carcinoma (ESCC) and…
New Report Urges Continued Investment in Infection Prevention Programs
Nearly five years after the onset of COVID-19, a new report from the World Health Organization (WHO) reveals limited progress in closing critical gaps in infection prevention and control (IPC)…
Dr. Reddy’s Launches Toripalimab in India, First Immuno-Oncology Drug for Nasopharyngeal Carcinoma
Dr. Reddy’s Laboratories Ltd has announced the launch of Toripalimab in India, marking a significant advancement in the treatment of nasopharyngeal carcinoma (NPC). Toripalimab, a New Biological Entity (NBE), is…
Global Head and Neck Cancer Therapeutics Market: 2024 Overview and 2030 Forecast
The global market for head and neck cancer therapeutics is estimated to reach $1.7 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of…